Archive

Medical Category: Hematology and Oncology

RESTART: REstart or STop Antithrombotics Randomized Trial

Background:  In patients with ICH, antiplatelet therapy is withheld due to the perceived risk of hematoma expansion.  Often, these medications are either not restarted or there is prolonged delays until they are restarted, but the risk of occlusive vascular events …

Read More
Hematology and Oncology

REBEL Review 90: Weight-Based Dosing of 4 Factor PCC

Read More
REBEL Reviews

REBEL Core Cast 14.0 – Superficial Venous Thrombosis

Take Home Points on SVT Superficial venous thrombosis refers to a clot and inflammation in the larger, or “axial” veins of the lower extremities and superficial thrombophlebitis refers to clot and inflammation in the tributary veins of the lower extremities. …

Read More
Hematology and Oncology

Tranexamic Acid (TXA) for Everything that Bleeds?

Background: TXA is a synthetic lysine derivative that binds with the lysine site on plasminogen and inhibits fibrinolysis.  TXA is not a new drug. Studies from the late 1960s and early 1970s have shown reduced bleeding and need for transfusions in …

Read More
Hematology and Oncology

REBEL Core Cast 7.0 – Oncologic Emergencies

Take Home Points on Oncologic Emergencies: Hyperviscosity Syndrome happens when elevated WBCs or severe hyperproteinemia cause high serum viscosity and micro-circulatory problems in patients with Waldenstrom’s macroglobulinemia, multiple myeloma or acute leukemia. Be suspicious of this syndrome in these patient’s when they present with the …

Read More
Hematology and Oncology

Sponsored